Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholder Deficit

v3.19.1
Condensed Consolidated Statement of Changes in Stockholder Deficit - USD ($)
Common Stock [Member]
Additional Paid-In-Capital [Member]
Deferred Compensation [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 122,675 $ 56,401,069 $ (10,125) $ (57,919,096) $ (1,405,477)
Balance, shares at Dec. 31, 2017 122,674,516        
Common stock grants to independent directors $ 185 49,815 50,000
Common stock grants to independent directors, shares 185,184        
Deferred compensation 10,125 10,125
Deferred compensation, shares        
Stock based compensation - options 69,500 69,500
Net loss (1,047,864) (1,047,864)
Balance at Mar. 31, 2018 $ 122,860 56,520,384 (58,966,960) (2,323,716)
Balance, shares at Mar. 31, 2018 122,859,700        
Balance at Dec. 31, 2018 $ 133,889 58,274,038 (61,943,318) (3,535,391)
Balance, shares at Dec. 31, 2018 133,888,573        
Common stock grants to independent directors $ 461 87,039 87,500
Common stock grants to independent directors, shares 460,525        
Common stock grant to service providers $ 37 6,338 6,375
Common stock grant to service providers, shares 37,500        
Stock based compensation - options 86,500 86,500
Restricted stock issuances $ 300 44,700 45,000
Restricted stock issuances, shares 299,998        
Net loss (1,135,420) (1,135,420)
Balance at Mar. 31, 2019 $ 134,687 $ 58,498,615 $ (63,078,738) $ (4,445,436)
Balance, shares at Mar. 31, 2019 134,686,596